Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class (Ascending) Administration Route Package Effective Date Package Discontinuation Date Status
54868-0451-02 54868-0451 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Feb. 8, 2005 In Use
54868-0451-06 54868-0451 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Feb. 8, 2005 In Use
69189-1105-01 69189-1105 Estrogens, Conjugated Premarin 0.9 mg/1 Hormonal Therapy Estrogen Oral Aug. 3, 2015 May 24, 2017 No Longer Used
52544-0092-76 52544-0092 Triptorelin Pamoate Trelstar Hormonal Therapy GnRH Agonist March 11, 2010 Oct. 31, 2018 No Longer Used
52544-0153-02 52544-0153 Triptorelin Pamoate Trelstar 3.75 mg/2mL Hormonal Therapy GnRH Agonist Intramuscular June 15, 2000 Oct. 31, 2018 No Longer Used
52544-0154-02 52544-0154 Triptorelin Pamoate Trelstar 11.25 mg/2mL Hormonal Therapy GnRH Agonist Intramuscular June 29, 2001 Oct. 31, 2018 No Longer Used
52544-0156-02 52544-0156 Triptorelin Pamoate Trelstar 22.5 mg/2mL Hormonal Therapy GnRH Agonist Intramuscular March 11, 2010 Oct. 31, 2018 No Longer Used
52544-0188-76 52544-0188 Triptorelin Pamoate Trelstar Hormonal Therapy GnRH Agonist June 29, 2001 Oct. 31, 2018 No Longer Used
52544-0189-76 52544-0189 Triptorelin Pamoate Trelstar Hormonal Therapy GnRH Agonist June 15, 2000 Oct. 31, 2018 No Longer Used
54868-2523-01 54868-2523 Erythropoietin Procrit 10000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Aug. 11, 1994 In Use
54868-5673-01 54868-5673 Erythropoietin Procrit 20000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous March 24, 2008 In Use
58468-1849-04 58468-1849 Thyrotropin Alfa Thyrogen Hormonal Therapy Thyroid Stimulating Hormone Nov. 30, 1998 May 30, 2019 No Longer Used
59385-0041-07 59385-0041 Naldemedine, naldemedine tosylate SYMPROIC 0.2 mg/1 Ancillary Therapy Opioid Antagonist Oral July 1, 2020 In Use
59385-0041-30 59385-0041 Naldemedine, naldemedine tosylate SYMPROIC 0.2 mg/1 Ancillary Therapy Opioid Antagonist Oral June 14, 2019 In Use
70518-2721-00 70518-2721 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral May 1, 2020 In Use
70518-3046-00 70518-3046 Raloxifene Raloxifene Hydrochloride 60.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral March 11, 2021 In Use
76282-0709-67 76282-0709 Lanreotide acetate Lanreotide Acetate 60.0 mg/.2mL Hormonal Therapy Somatostatin Analog Subcutaneous June 1, 2022 Aug. 18, 2023 In Use
76282-0710-67 76282-0710 Lanreotide acetate Lanreotide Acetate 90.0 mg/.3mL Hormonal Therapy Somatostatin Analog Subcutaneous June 1, 2022 Aug. 18, 2023 In Use
76282-0711-67 76282-0711 Lanreotide acetate Lanreotide Acetate 120.0 mg/.5mL Hormonal Therapy Somatostatin Analog Subcutaneous June 1, 2022 Aug. 18, 2023 In Use
00409-4215-01 00409-4215 Zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous Oct. 19, 2017 In Use
00409-4215-05 00409-4215 Zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous March 18, 2019 June 1, 2022 In Use
00115-1408-01 00115-1408 Methyltestosterone Methyltestosterone 10.0 mg/1 Hormonal Therapy Androgen Oral Sept. 21, 2015 In Use
00115-1408-03 00115-1408 Methyltestosterone Methyltestosterone 10.0 mg/1 Hormonal Therapy Androgen Oral Sept. 21, 2015 In Use
00115-1408-08 00115-1408 Methyltestosterone Methyltestosterone 10.0 mg/1 Hormonal Therapy Androgen Oral Sept. 21, 2015 In Use
17478-0327-05 17478-0327 Zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous May 22, 2014 In Use

Found 10,000 results in 5 milliseconds — Export these results